You are here

HEALTHSIM, INC.

Company Information
Address
101 W. 23rd Street, #525
New York, NY 10011-2490
United States



Information

DUNS: 786529482

# of Employees: 3


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Computer-based Prescription Opioid Abuse Prevention for Adolescents

    Amount: $912,129.00

    DESCRIPTION provided by applicant Recreational use of prescription opioids among adolescents is a significant and growing public health concern and has been referred to as an emerging epidemic in t ...

    STTRPhase II2014Department of Health and Human Services National Institutes of Health
  2. Computer-based Prescription Opioid Abuse Prevention for Adolescents

    Amount: $99,958.00

    DESCRIPTION (provided by applicant): Recreational use of prescription opioids among adolescents is a significant and growing public health concern and has been referred to as an emerging epidemic in t ...

    STTRPhase I2008Department of Health and Human Services National Institutes of Health
  3. Expanding Computer-Based Drug Abuse Prevention

    Amount: $750,001.00

    Recent evidence indicates that the prevalence of substance abuse is significant among children and adolescents, and initiation of drug use is often occurring at very early ages. These findings under ...

    STTRPhase II2006Department of Health and Human Services National Institutes of Health
  4. Expanding Computer-Based Drug Abuse Prevention

    Amount: $750,001.00

    Recent evidence indicates that the prevalence of substance abuse is significant among children and adolescents, and initiation of drug use is often occurring at very early ages. These findings under ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  5. Applying Web Technology to Buprenorphine Treatment

    Amount: $0.00

    DESCRIPTION (provided by applicant): The partial opioid agonist buprenorphine, is expected to be approved by the FDA in the very near future for the treatment of opioid-dependence and will be availabl ...

    STTRPhase I2003Department of Health and Human Services National Institutes of Health
  6. Applying Web Technology to Buprenorphine Treatment

    Amount: $499,919.00

    DESCRIPTION (provided by applicant): The partial opioid agonist buprenorphine, is expected to be approved by the FDA in the very near future for the treatment of opioid-dependence and will be availabl ...

    STTRPhase II2003Department of Health and Human Services National Institutes of Health
  7. EXPANDING COMPUTER-BASED DRUG ABUSE PREVENTION

    Amount: $100,000.00

    DESCRIPTION (provided by investigator): Recent evidence indicates that drug use is highly prevalent among children and adolescents, and initiation of drug use is often occurring at very early ages. ...

    STTRPhase I2002Department of Health and Human Services National Institutes of Health
  8. Applying Web Technology to Buprenorphine Treatment

    Amount: $100,000.00

    The partial opioid agonist buprenorphine, is expected to be approved by the FDA in the very near future for the treatment of opioid-dep ...

    STTRPhase I2001Department of Health and Human Services National Institutes of Health
  9. N/A

    Amount: $0.00

    N/A

    STTRPhase I2000Department of Health and Human Services National Institutes of Health
  10. N/A

    Amount: $417,671.00

    N/A

    STTRPhase II2000Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government